Informed Consent
Q&A – The New Normal: Considerations for Restarting Research
Experts answer some of the most popular audience questions from the recent webinar The New Normal: Considerations for Restart Research. Read more:
Patient Engagement and the IRB
With increased efforts to engage and include patient and participant communities more closely in research, when does an IRB review become required?
Trial Design in the Time of COVID-19: Complex and Efficient
Complex trial designs can eliminate less-promising investigational treatments quickly to speed development, but they remain under-utilized. Read more:
Keep in Touch: Tips for Working with a Single IRB for the First Time
Recent regulations and policies have many institutions establishing policies and processes for working with an external sIRB. Read more:
Q&A – Ask Advarra Live: The Real-World Impact of COVID-19 on Research
We have addressed the most popular Q&A topics from our recent webinar on the research impact of COVID-19 in this blog post. Read more:
Differentiating “Public” and “Private” Internet Spaces in IRB Review
The difference between “public” and “private” internet spaces has gained importance with the growing research use of internet and social media platforms as data sources. Read more:
Q&A Part 1 – Evaluating Payment to Participate in Research: Ethical and Regulatory Issues
Dr. Gelinas answers audience questions we weren’t able to address during the webinar.
IRB Review of Coronavirus and Other Emerging Infectious Disease Research: Issues to Consider
Advarra IRB experts discuss unique issues that research involving emerging infectious diseases like coronavirus can raise for IRB review. Read more:
Informed Consent: 6 Approaches to Increase Participant Comprehension
Explore six approaches for improving informed consent and supporting participants’ understanding of the studies they are asked to join.
Revised Common Rule Compliance Now in Full Effect—and What That Means
The Revised Common Rule is here after multiple delays, exceptions, and many training sessions. As of January 20, 2020, this regulation is in full effect.
Making Sense of the New HUD Guidance
Understand how the new HUD guidance clarifies responsibilites of the IRB and institutions, while widening the access of small communities to HUDs.
Compensating Clinical Trial Participants: The Basics
Participant compensation is often a complicated matter. This blog will shed light on what an IRB considers during its review.
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.